Kamada (KMDA) Cash from Investing Activities Growth (1y) (2014 - 2026)
Kamada (KMDA) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.93% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 57.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -186.78% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 551.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 526.11% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -3,664.79% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -3.45% |
| 10 | Kamada | 399.49 Mn | 326.34 Mn | 19.12 Mn | -2,721.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,721.78% |
| Dec 31, 2025 | 5.10% |
| Sep 30, 2025 | -68.97% |
| Jun 30, 2025 | 33.07% |
| Mar 31, 2025 | 45.56% |
| Dec 31, 2024 | -48.20% |
| Sep 30, 2024 | -22.85% |
| Jun 30, 2024 | -187.12% |
| Mar 31, 2024 | -245,279.69% |
| Dec 31, 2023 | -101.94% |
| Sep 30, 2023 | -106,892.57% |
| Jun 30, 2023 | -54.57% |
| Mar 31, 2023 | 99.79% |
| Dec 31, 2022 | 98.98% |
| Sep 30, 2022 | -100.00% |
| Jun 30, 2022 | -106.38% |
| Mar 31, 2022 | 95.13% |
| Dec 31, 2021 | -1,727.18% |
| Sep 30, 2021 | 2,453.27% |
| Jun 30, 2021 | 1,164.56% |